作者
Anders Gustavsson, Mikael Svensson, Frank Jacobi, Christer Allgulander, Jordi Alonso, Ettore Beghi, Richard Dodel, Mattias Ekman, Carlo Faravelli, Laura Fratiglioni, Brenda Gannon, David Hilton Jones, Poul Jennum, Albena Jordanova, Linus Jönsson, Korinna Karampampa, Martin Knapp, Gisela Kobelt, Tobias Kurth, Roselind Lieb, Mattias Linde, Christina Ljungcrantz, Andreas Maercker, Beatrice Melin, Massimo Moscarelli, Amir Musayev, Fiona Norwood, Martin Preisig, Maura Pugliatti, Juergen Rehm, Luis Salvador-Carulla, Brigitte Schlehofer, Roland Simon, Hans-Christoph Steinhausen, Lars Jacob Stovner, Jean-Michel Vallat, Peter Van den Bergh, Jim van Os, Pieter Vos, Weili Xu, Hans-Ulrich Wittchen, Bengt Jönsson, Jes Olesen, CDBE2010 Study Group
发表日期
2011/10/1
期刊
European neuropsychopharmacology
卷号
21
期号
10
页码范围
718-779
出版商
Elsevier
简介
BACKGROUND
The spectrum of disorders of the brain is large, covering hundreds of disorders that are listed in either the mental or neurological disorder chapters of the established international diagnostic classification systems. These disorders have a high prevalence as well as short- and long-term impairments and disabilities. Therefore they are an emotional, financial and social burden to the patients, their families and their social network. In a 2005 landmark study, we estimated for the first time the annual cost of 12 major groups of disorders of the brain in Europe and gave a conservative estimate of €386billion for the year 2004. This estimate was limited in scope and conservative due to the lack of sufficiently comprehensive epidemiological and/or economic data on several important diagnostic groups. We are now in a position to substantially improve and revise the 2004 estimates. In the present report we …
引用总数
学术搜索中的文章
A Gustavsson, M Svensson, F Jacobi, C Allgulander… - European neuropsychopharmacology, 2011
A Gustavsson - European Neuropsychopharmacology